Clinical Trial: Effect of Low-dose Esketamine on Maternal Depression at 2 Years After Childbirth
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition:
Prenatal Depression
Ketamine
Postpartum Depression
Study Type: Interventional
Official Title: Effect of Intravenous Low-dose Esketamine on Maternal Depression at 2 Years After Childbirth in Women With Prenatal Depression: 2-year Follow-up of a Randomized Controlled Trial
Brief Summary:
Postpartum depression refers to the depression after childbirth, which is a common mental disorder in women. The pathogenesis of postpartum depression is not fully understood, and may be related to a variety of factors. Prenatal depression is an important risk factor for postpartum depression. Our recent multicenter randomized controlled trial, "Effect of Low-dose esketamine on the incidence of postpartum depression in women with prenatal depression", explored the effect of immediate postpartum intravenous…
Read more